Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Rekha Hemrajani currently holds 49,579 shares of MAXCYTE, INC. (MXCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rekha Hemrajani has been a net buyer of MXCT stock. They have purchased $57.0K and sold $22.3K worth of shares.
Rekha Hemrajani's most recent insider trade was on Jun 17, 2026, when they sold 49,579 shares at $0.00 per share.
Rekha Hemrajani serves as Executive at MAXCYTE, INC. (MXCT). They have executed 13 insider transactions totaling $79.3K over their tenure at the company.
Rekha Hemrajani holds the position of Executive at MAXCYTE, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Rekha Hemrajani has shown a buying trading pattern, with $57.0K in total purchases and $22.3K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Rekha Hemrajani was on Jul 21, 2020, when they purchased $57.0K worth of ALXO shares. This transaction involved 3,000 shares at $19.00 per share.
Rekha Hemrajani currently owns 49,579 shares of MAXCYTE, INC. (MXCT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Rekha Hemrajani's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Rekha Hemrajani has 13 Form 4 filings on record as an insider at MAXCYTE, INC..
Set alerts for Rekha Hemrajani and 40,000+ other insiders.